Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/22/2018 |
| Start Date: | August 2007 |
| End Date: | December 2018 |
Fluorine-18 Fluorodeoxyglucose (F-18 FDG) PET/CT is established as a powerful imaging tool
for cancer detection and monitoring response to therapy. Sodium Fluorine-18 (F-18) was used
in the 1970s for bone scanning and can be used as a skeletal tracer in current PET/CT
scanners. The combined administration of F-18 and F-18 FDG in a single PET/CT scan for cancer
detection was not attempted to date. We hope to learn what is the best approach for detection
of cancer and thus to improve cancer treatment.
for cancer detection and monitoring response to therapy. Sodium Fluorine-18 (F-18) was used
in the 1970s for bone scanning and can be used as a skeletal tracer in current PET/CT
scanners. The combined administration of F-18 and F-18 FDG in a single PET/CT scan for cancer
detection was not attempted to date. We hope to learn what is the best approach for detection
of cancer and thus to improve cancer treatment.
Inclusion Criteria:
- Patients older than 18-year-old, diagnosed with cancer
- Patients must understand and voluntarily sign an Informed Consent form after the
contents have been fully explained to them
Exclusion Criteria:
- Patients who cannot complete a PET/CT scan
- Pregnant women
- Healthy volunteers
- Patients participating in other research studies
The subjects will not be paid to participate in this protocol. No costs will be charged to
the subjects.
We found this trial at
2
sites
291 Campus Dr
Stanford, California 94305
Stanford, California 94305
(650) 725-3900
Principal Investigator: Andrei Iagaru, MD
Phone: 650-736-2859
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
Click here to add this to my saved trials